WEBMD HEALTH CORP. ANNOUNCES FINAL
RESULTS OF ITS TENDER OFFER
NEW YORK, NY (September 14, 2010) — WebMD Health Corp. (Nasdaq: WBMD) announced today
the final results of its tender offer to purchase up to 3,000,000 shares of its Common Stock at a price of $52.00
per share, which expired at 5:00 p.m., New York City time, on September 8, 2010.
WebMD has accepted for purchase 3,000,000 shares of its Common Stock, including all “odd lots” properly
tendered, at a purchase price of $52.00 per share, for a total cost of approximately $156 million. Based on the
final tabulation by American Stock Transfer & Trust Company, the Depositary for the tender offer, 13,978,001
shares of WebMD Common Stock were properly tendered and not withdrawn or tendered conditionally.
WebMD has been informed by the Depositary that, after giving effect to the priority for “odd lots,” the final
proration factor is approximately 20.79%.
The Depositary will promptly issue payment for the shares validly tendered and accepted for purchase and
will return all other shares tendered.
Immediately following the purchase of the tendered shares, WebMD expects to have approximately
57.0 million shares of its Common Stock outstanding (excluding approximately 1.2 million unvested shares of
restricted stock) and to have approximately $350 million in cash and cash equivalents. As of the close of trading
on September 13, 2010, there were approximately $86.3 million aggregate principal amount of WebMD’s 3
1/8% Convertible Notes outstanding, which are convertible into an aggregate of approximately 2.5 million shares
of WebMD Common Stock.
The Information Agent for the tender offer is Innisfree M&A Incorporated. For questions and information,
please call the Information Agent toll free at 1-888-750-5834.
THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT
CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL SHARES
OF WEBMD HEALTH CORP. COMMON STOCK. TH